Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3387-3395

  Hunter, Howard N ^a   Ross Demcoe, A ^a   Jenssen, Håvard ^b   Gutteberg, Tore J ^b   Vogel, Hans J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLUTAMINE; LACTOFERRICIN; LYSINE; MEMBRANE MIMETIC SOLVENT; SOLVENT; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; AQUEOUS SOLUTION; ARTICLE; BACTERICIDAL ACTIVITY; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CRYSTAL STRUCTURE; HUMAN; HYDROPHOBICITY; MEMBRANE; MOLECULAR MIMICRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; STOMACH; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; HUMANS; LACTOFERRIN; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN FOLDING; SEQUENCE ANALYSIS, DNA; SOLUTIONS; SOLVENTS; WATER;

EID: 23044463641     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3387-3395.2005     Document Type: Article

References (48)

1. Aguilera, O., H. Ostolaza, L. M. Quiros, and J. F. Fierro. 1999. Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes. FEBS Lett. 462:273-277.
2. Andersen, J. H., H. Jenssen, and T. J. Gutteberg. 2003. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antivir. Res. 58:209-215.
3. Andersen, J. H., H. Jenssen, K. Sandvik, and T. J. Gutteberg. 2004. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 74:262-271.
4. Andersen, J. H., S. A. Osbakk, L. H. Vorland, T. Traavik, and T. J. Gutteberg. 2001. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antivir. Res. 51:141-149.
5. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
6. Arnold, R. R., M. F. Cole, and J. R. McGhee. 1977. A bactericidal effect for human lactoferrin. Science 197:263-265.
7. Azuma, M., T. Kojima, I. Yokohama, H. Tajiri, K. Yoshikawa, S. Saga, and C. A. Del Carpio. 1999. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin. J. Pept. Res. 54:237-241.
8. Bellamy, W., M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121:130-136.
9. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54(Pt 5):905-921.
10. Chapple, D. S., R. Hussain, C. L. Joannou, R. E. Hancock, E. Odell, R. W. Evans, and G. Siligardi. 2004. Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide. Antimicrob. Agents Chemother. 48:2190-2198.
11. Chapple, D. S., D. J. Mason, C. L. Joannou, E. W. Odell, V. Gant, and R. W. Evans. 1998. Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect. Immun. 66:2434-2440.
12. Cornwell, G. G., III, K. Sletten, B. Johansson, and P. Westermark. 1988. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem. Biophys. Res. Commun. 154: 648-653.
13. Crowhurst, K. A., and J. D. Forman-Kay. 2003. Aromatic and methyl NOEs highlight hydrophobic clustering in the unfolded state of an SH3 domain. Biochemistry 42:8687-8695.
14. Delaglio, F., S. Grzesiek, G. W. Vuister, G. Zhu, J. Pfeifer, and A. Bax. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6:277-293.
15. Dyson, H. J., and P. E. Wright. 1995. Antigenic peptides. FASEB J. 9:37-42.
16. Elass-Rochard, E., D. Legrand, V. Salmon, A. Roseanu, M. Trif, P. S. Tobias, J. Mazurier, and G. Spik. 1998. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66:486-491.
17. +- transporting subunit c of the F1F0 ATP synthase. Biochemistry 37:8817-8824.
18. Gustafson, K. R., L. K. Walton, R. C. Sowder, Jr., D. G. Johnson, L. K. Pannell, J. H. Cardellina, Jr., and M. R. Boyd. 2000. New circulin macrocyclic polypeptides from Chassalia parvifolia. J. Nat. Prod. 63:176-178.
19. Haukland, H. H., H. Ulvatne, K. Sandvik, and L. H. Vorland. 2001. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 508:389-393.
20. Hunter, H. N., D. B. Fulton, T. Ganz, and H. J. Vogel. 2002. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. 277:37597-37603.
21. Hwang, P. M., N. Zhou, X. Shan, C. H. Arrowsmith, and H. J. Vogel. 1998. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37:4288-4298.
22. Hwang, T. L., and A. J. Shaka. 1995. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112:275-279.
23. Jenssen, H., J. H. Andersen, D. Mantzilas, and T. J. Gutteberg. 2004. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antivir. Res. 64:119-126.
24. Jenssen, H., J. H. Andersen, L. Uhlin-Hansen, T. J. Gutteberg, and O. Rekdal. 2004. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antivir. Res. 61:101-109.
25. Klein-Seetharaman, J., M. Oikawa, S. B. Grimshaw, J. Wirmer, E. Duchardt, T. Ueda, T. Imoto, L. J. Smith, C. M. Dobson, and H. Schwalbe. 2002. Long-range interactions within a nonnative protein. Science 295:1719-1722.
26. Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 14:51-55.
27. Kuwata, H., T. T. Yip, M. Tomita, and T. W. Hutchens. 1998. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta 1429:129-141.
28. Kuwata, H., T. T. Yip, C. L. Yip, M. Tomita, and T. W. Hutchens. 1998. Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem. Biophys. Res. Commun. 245:764-773.
29. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291.
30. Lupetti, A., A. Paulusma-Annema, M. M. Welling, S. Senesi, J. T. Van Dissel, and P. H. Nibbering. 2000. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44:3257-3263.
31. Morris, A. L., M. W. H. E. G. MacArthur, and J. M. Thornton. 1992. Stereochemical quality of protein structure coordinates. Proteins 12:345-364.
32. Nguyen, L. T., D. J. Schibli, and H. J. Vogel. 2005. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. J. Pept. Sci. 11:379-389.
33. Nilges, M., and S. I. O'Donoghue. 1998. Ambiguous NOEs and automated NOE assignment. Prog. NMR Spectr. 32:107-139.
34. Sallmann, F. R., S. Baveye-Descamps, F. Pattus, V. Salmon, N. Branza, G. Spik, and D. Legrand. 1999. Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects. J. Biol. Chem. 274:16107-16114.
35. Schibli, D. J., P. M. Hwang, and H. J. Vogel. 1999. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 446:213-217.
36. Schwaiger, M., M. Lebendiker, H. Yerushalmi, M. Coles, A. Groger, C. Schwarz, S. Schuldiner, and H. Kessler. 1998. NMR investigation of the multidrug transporter EmrE, an integral membrane protein. Eur. J. Biochem. 254:610-619.
37. Strom, M. B., O. Rekdal, and J. S. Svendsen. 2000. Antibacterial activity of 15-residue lactoferricin derivatives. J. Pept. Res. 56:265-274.
38. Ulvatne, H., O. Samuelsen, H. H. Haukland, M. Kramer, and L. H. Vorland. 2004. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 237:377-384.
39. van Berkel, P. H., M. E. Geerts, H. A. van Veen, M. Mericskay, H. A. de Boer, and J. H. Nuijens. 1997. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328(Pt 1):145-151.
40. Vogel, H. J., D. J. Schibli, W. Jing, E. M. Lohmeier-Vogel, R. F. Epand, and R. M. Epand. 2002. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80:49-63.
41. Vorland, L. H., H. Ulvatne, J. Andersen, H. Haukland, O. Rekdal, J. S. Svendsen, and T. J. Gutteberg. 1998. Lactoferricin of bovine origin is more active than lactoferricins of human, murinc and caprine origin. Scand. J. Infect. Dis. 30:513-517.
42. Wakabayashi, H., M. Takase, and M. Tomita. 2003. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 9:1277-1287.
43. Weinberg, E. D. 1974. Iron and susceptibility to infectious disease. Science 184:952-956.
44. Weljie, A. M., A. P. Yamniuk, H. Yoshino, Y. Izumi, and H. J. Vogel. 2003. Protein conformational changes studied by diffusion NMR spectroscopy: application to helix-loop-helix calcium binding proteins. Protein Sci. 12:228-236.
45. Wishart, D. S., B. D. Sykes, and F. M. Richards. 1992. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
46. Wuthrich, K. 1986. NMR of proteins and nucleic acids. John Wiley & Sons Inc., New York, N.Y.
47. Zhang, G. H., D. M. Mann, and C. M. Tsai. 1999. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67:1353-1358.
48. Zhou, N., D. P. Tieleman, and H. J. Vogel. 2004. Molecular dynamics simulations of bovine lactoferricin: turning a helix into a sheet. Biometals 17: 217-223.